BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
+12.09%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$2.04B
AUM Growth
+$2.04B
Cap. Flow
+$211M
Cap. Flow %
10.36%
Top 10 Hldgs %
52.83%
Holding
78
New
7
Increased
4
Reduced
2
Closed
3

Top Buys

1
SRPT icon
Sarepta Therapeutics
SRPT
$107M
2
SGEN
Seagen Inc. Common Stock
SGEN
$40.5M
3
ELVN icon
Enliven Therapeutics
ELVN
$15.6M
4
RVMD icon
Revolution Medicines
RVMD
$15.2M
5
IOVA icon
Iovance Biotherapeutics
IOVA
$13.4M

Top Sells

1
GERN icon
Geron
GERN
$19.6M
2
ARVN icon
Arvinas
ARVN
$5.13M
3
FATE icon
Fate Therapeutics
FATE
$4.28M
4
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$577K
5
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
$41K

Sector Composition

1 Healthcare 99.75%
2 Financials 0.25%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RXDX
1
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$204M 10% 1,897,500 – –
RETA
2
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$112M 5.49% 1,230,004 – –
ONC
3
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$108M 5.29% 500,000 – –
SRPT icon
4
Sarepta Therapeutics
SRPT
$1.78B
$107M 5.25% +775,000 New +$107M
APLS icon
5
Apellis Pharmaceuticals
APLS
$3.48B
$104M 5.11% 1,576,000 – –
TYRA icon
6
Tyra Biosciences
TYRA
$675M
$104M 5.09% 6,448,359 – –
RVMD icon
7
Revolution Medicines
RVMD
$7.1B
$101M 4.98% 4,684,264 +700,000 +18% +$15.2M
SWTX
8
DELISTED
SpringWorks Therapeutics
SWTX
$88.1M 4.33% 3,421,541 – –
MRTX
9
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$74.4M 3.65% 2,000,000 – –
CYTK icon
10
Cytokinetics
CYTK
$4.23B
$73.9M 3.63% 2,100,000 – –
AMLX icon
11
Amylyx Pharmaceuticals
AMLX
$836M
$61.1M 3% 2,084,000 – –
SAGE
12
DELISTED
Sage Therapeutics
SAGE
$45.9M 2.26% 1,094,000 – –
SGEN
13
DELISTED
Seagen Inc. Common Stock
SGEN
$40.5M 1.99% +200,000 New +$40.5M
RLAY icon
14
Relay Therapeutics
RLAY
$619M
$35.7M 1.76% 2,169,132 – –
MRUS icon
15
Merus
MRUS
$4.98B
$35M 1.72% 1,900,000 – –
VKTX icon
16
Viking Therapeutics
VKTX
$3.04B
$33.3M 1.64% 2,000,000 +500,000 +33% +$8.33M
ETNB icon
17
89bio
ETNB
$1.34B
$32M 1.57% 2,100,000 +700,000 +50% +$10.7M
AKRO icon
18
Akero Therapeutics
AKRO
$3.74B
$31.8M 1.56% 831,495 – –
NUVL icon
19
Nuvalent
NUVL
$5.52B
$31.6M 1.55% 1,210,192 – –
IDYA icon
20
IDEAYA Biosciences
IDYA
$2.15B
$30.2M 1.49% 2,202,812 – –
ITOS icon
21
iTeos Therapeutics
ITOS
$29.3M 1.44% 2,154,058 – –
VTYX icon
22
Ventyx Biosciences
VTYX
$171M
$28.5M 1.4% 850,000 – –
ANAB icon
23
AnaptysBio
ANAB
$569M
$28.3M 1.39% 1,300,000 – –
TNGX icon
24
Tango Therapeutics
TNGX
$747M
$28.1M 1.38% 7,123,642 – –
RCUS icon
25
Arcus Biosciences
RCUS
$1.13B
$26.1M 1.28% 1,432,200 – –
1
2 3 4